Details

Letter to the acting Chairperson and Chief Executive Officer of the Patented Medicine Prices Review Board - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 2, 2026 · edition #6
Timestamp: 2026-01-02T16:28:36.715Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/costs-prices/letter-acting-chairperson-chief-executive-officer-patented-medicine-prices-review-board.html
Replay URL: https://replay.healtharchive.ca/job-6/20260102162836/https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/costs-prices/letter-acting-chairperson-chief-executive-officer-patented-medicine-prices-review-board.html#ha_snapshot=436693
ID: 436693
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots